Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02732847
Other study ID # worrall1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2007
Est. completion date March 2009

Study information

Verified date June 2006
Source Memorial University of Newfoundland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Delayed prescriptions have been shown to lower antibiotic use for upper respiratory tract infections (which are mostly viral). This trial will test the hypothesis that if the clinician post-dates the delayed prescription by 2 days, rather than dating it on the day the patient is seen, there will be a further drop in the rate of antibiotic use.


Description:

6 family doctors and 2 nurse practitioners in a small rural town will issue delayed antibiotic prescriptions to adult patients with new acute respiratory tract infections. The delayed prescriptions will be randomly dated for either the day of the office visit, or 2 days later. The 2 local pharmacies will note whether the prescription is cashed, and when. It is hypothesised that post-dating the prescription will result in a reduced cashing rate. Each arm of the study (Usual v Post-Dated) will contain 75 subjects. This sample will have the power to detect a 25% change in prescription use.


Recruitment information / eligibility

Status Completed
Enrollment 149
Est. completion date March 2009
Est. primary completion date March 2009
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults aged 18 years or older - Adults with an untreated upper respiratory tract infection - Adults presenting for the first time to a family physician or a nurse practitioner Exclusion Criteria: - Less that 18 years - Having a clear indication for antibiotic therapy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
A delayed prescription dated 2 days after clinical office visit

Drug:
Usual Dated


Locations

Country Name City State
Canada Memorial University St John's Newfoundland and Labrador

Sponsors (1)

Lead Sponsor Collaborator
Memorial University of Newfoundland

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants That Filled a Prescription in 20 Days Prescriptions 20 days
See also
  Status Clinical Trial Phase
Completed NCT00887172 - Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs) Phase 4
Completed NCT00228254 - Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study Phase 4
Completed NCT01151202 - Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "AG NPP709 Syrup" Phase 3
Completed NCT01765920 - Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults Phase 3
Completed NCT01843842 - Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children Phase 3